- Phosphodiesterase Type 5 Inhibitors and Risk of Skin Cancers in Men: A Meta-Analysis and Trial Sequential Analysis Involving 7,479,852 Subjects
-
Lu YP, Fan S, Liang Z, Song Y, Liu K, Zhou K, Wang X, Kang J, Yang Y, Liu X
- KMID: 2519910
- World J Mens Health.
- 2021 Oct;39(4):683-696.
- doi: 10.5534/wjmh.200082
Purpose: We conducted a systematic review and meta-analysis to quantify the association between phosphodiesterase type 5 inhibitors (PDE5Is) use and skin cancers and we also examined whether down-expression of the... -
- CITED
-
- Close
- SHARE
-
- Close
